1-n-me-tyr(1)-7-n-me-arg-8-n-et-leunh2-dynorphin (1-8) has been researched along with u-50488 in 5 studies
Studies (1-n-me-tyr(1)-7-n-me-arg-8-n-et-leunh2-dynorphin (1-8)) | Trials (1-n-me-tyr(1)-7-n-me-arg-8-n-et-leunh2-dynorphin (1-8)) | Recent Studies (post-2010) (1-n-me-tyr(1)-7-n-me-arg-8-n-et-leunh2-dynorphin (1-8)) | Studies (u-50488) | Trials (u-50488) | Recent Studies (post-2010) (u-50488) |
---|---|---|---|---|---|
35 | 2 | 0 | 1,664 | 3 | 209 |
Protein | Taxonomy | 1-n-me-tyr(1)-7-n-me-arg-8-n-et-leunh2-dynorphin (1-8) (IC50) | u-50488 (IC50) |
---|---|---|---|
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 2.15 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0027 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 2.15 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.7171 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0958 | |
Kappa-type opioid receptor | Homo sapiens (human) | 0.0537 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akil, H; Goldstein, A; Mansour, A; Meng, F; Thompson, RC; Watson, SJ; Xie, GX | 1 |
Kaneko, T; Nakazawa, T; Yamanishi, Y | 1 |
Furuya, Y; Kaneko, T; Nakazawa, T; Tachibana, S; Yamatsu, K; Yoshino, H | 1 |
Funada, M; Misawa, M; Nagase, H; Narita, M; Suzuki, T | 1 |
Ambo, A; Hiramatsu, M; Inoue, K; Kameyama, T; Sasaki, Y | 1 |
5 other study(ies) available for 1-n-me-tyr(1)-7-n-me-arg-8-n-et-leunh2-dynorphin (1-8) and u-50488
Article | Year |
---|---|
Cloning and pharmacological characterization of a rat kappa opioid receptor.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Amino Acid Sequence; Analgesics; Animals; Benzeneacetamides; Cell Line; Cell Membrane; Cloning, Molecular; Corpus Striatum; Cyclic AMP; DNA Primers; DNA, Complementary; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Gene Library; In Situ Hybridization; Inositol 1,4,5-Trisphosphate; Kinetics; Ligands; Molecular Sequence Data; Pyrrolidines; Rats; Receptors, Opioid, kappa; Restriction Mapping; RNA, Messenger; Transfection | 1993 |
A comparative study of monoaminergic involvement in the antinociceptive action of E-2078, morphine and U-50,488E.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesia; Analgesics; Animals; Biogenic Monoamines; Drug Interactions; Dynorphins; Male; Mice; Morphine; Neurotoxins; Peptide Fragments; Pyrrolidines | 1991 |
Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesia; Analgesics; Animals; Buprenorphine; Drug Interactions; Dynorphins; Male; Mice; Morphine; Naloxone; Peptide Fragments; Pyrrolidines; Receptors, Opioid | 1990 |
Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Analgesics; Animals; Apomorphine; Conditioning, Operant; Dopamine; Dynorphins; Homovanillic Acid; Injections, Subcutaneous; Limbic System; Male; Mice; Mice, Inbred Strains; Morphine; Motivation; Naltrexone; Peptide Fragments; Prosencephalon; Pyrrolidines; Receptors, Opioid, kappa; Reward | 1993 |
Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Acetic Acid; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Behavior, Animal; Dynorphins; Guinea Pigs; Hot Temperature; In Vitro Techniques; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Mice; Narcotic Antagonists; Oligopeptides; Pain Measurement; Peptide Fragments; Reaction Time; Receptors, Opioid | 2001 |